CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 103 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $121,753 | +91.7% | 3,169 | +15.5% | 0.01% | +100.0% |
| Q1 2023 | $63,524 | -19.3% | 2,744 | -8.7% | 0.00% | -25.0% |
| Q4 2022 | $78,705 | +33.3% | 3,004 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $59,059 | +27.3% | 3,004 | +13.2% | 0.00% | +50.0% |
| Q2 2022 | $46,401 | +25.4% | 2,653 | +17.3% | 0.00% | +100.0% |
| Q1 2022 | $36,990 | -76.3% | 2,261 | -76.4% | 0.00% | -50.0% |
| Q4 2021 | $156,299 | +27.8% | 9,583 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $122,279 | -9.6% | 9,583 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $135,312 | +89.5% | 9,583 | +112.8% | 0.00% | +100.0% |
| Q4 2020 | $71,418 | – | 4,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
| Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
| FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
| Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
| Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
| Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
| EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
| Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |